Advanced Cell Technology (ACT; stock symbol ACTC) announced that it has secured $35 million in funding from investment company, Lincoln Park Capital. The press release quotes CEO Gary Rabin: “We are most pleased about this financing agreement, as it has a number of notable benefits for the company,” commented Gary Rabin, chairman and CEO of …
Stem Cell Biotech Advanced Cell Technology (ACT) gets $35 million Read More »
Qu’est-ce que les cellules souches? French Qu’est-ce que les cellules souches? Le corps humain est composé de centaines de différentes populations de cellules, lesquelles permettent à notre corps de fonctionner correctement et ainsi, elles sont essentielles dans le maintient d’une bonne santé. Par exemple, les cellules forment nos organes et donc permettent à notre cœur …
I recently posted a poll (you can still vote here) asking readers what they thought was the biggest stem cell news story of the year. Surprisingly, when the poll first went up, almost all the votes went to the Vatican Stem Cell Meeting, but then as we started getting a larger number of votes, things …
Biggest stem cell story of the year poll results are surprising Read More »
Last year around this time I presented my first stem cell awards of the year, in that case for 2010. You can see whom I thought deserved awards here. Now it is time for our 2011 stem cell awards. These awards reflect my opinions and those not mentioned will hopefully forgive me as there is …
A year from now will I still be conducted federally funded research on human ES cells? What about the hundreds of other professors in the U.S. and their thousands of employees? It is not unreasonable at this point to forecast a perfect storm in Fall 2012 that may kill elements of stem cell research that …
The perfect storm in Fall 2012 that may kill stem cell research Read More »
Each year at this time I start thinking about what the next year will bring for the stem cell field and make predictions. This year is no different and I’ve been pondering what 2012 has in store for us. You can read my predictions for 2011 here and see how I fared. Not too bad, but overly optimistic …
Stem cell predictions for 2012: Science, CIRM, ACT, trends Read More »
Sometimes a top scientist makes news with a quote on research and that happened with Ian Wilmut recently on stem cells. Move away from research on human ES cells (hESC) in favor of very new and still largely unclear trans-differentiation technology? I say, no way. But, Bradley Fikes of the North County Times has reported …
Ian Wilmut, Dolly’s dad, says dump hESC? What does this mean? Read More »
Many of us have been discouraged by Geron’s decision to end their stem cell program, which included products based on human embryonic stem (ES) cells, but let’s keep some perspective on this and not give up hope. The opponents of hope want us to give up. They who have waged their own self-proclaimed war on …
What with the Mississippi “personhood” amendment up for a vote today and also the Vatican Adult Stem Cell Conference beginning tomorrow, I thought today was a good time for a post about adult versus embryonic stem cells. Does stem cell research have to be either/or? Adult or stem? Can’t someone be for both adult and …
Key points about adult versus embryonic stem cells Read More »
In mid-November the Catholic Church, in fact the Vatican itself, will do something it has never done before in its very long existence. It will hold a conference on stem cells. Perhaps equally unusual and of interest is the fact that the basis for this conference is a $1 million (USD) gamble by the Vatican …
More on the Vatican $1 million gamble on NeoStem and their upcoming conference in Rome Read More »